Figure 1.Cumulative number of survived events in patients with metastatic melanoma undergoing chemotherapy and immunotherapy. (A–C) The Log-rank test for overall survival, disease specific survival, and progression-free interval survival curves of the chemotherapy and immunotherapy groups. (D) Survival curves of overall survival of male and female patients.
